ARCHIVES

BRCA 1 Mutation Finding Draws Attention To Potential Perils Of Genetic Testing

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Big Get Bigger, Litton Primate Contract Renewed

September 19, 1975

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

September 12, 2014

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors

June 29, 2001